Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer.
Rebhan K, Stelzer PD, Pradere B, Rajwa P, Kramer G, Hofmann B, Resch I, Yurdakul O, Laccone FA, Bujalkova MG, Smogavec M, Tan YY, Ristl R, Shariat SF, Egger G, Hassler MR.
Rebhan K, et al. Among authors: kramer g.
World J Urol. 2023 Aug;41(8):2091-2097. doi: 10.1007/s00345-023-04535-4. Epub 2023 Aug 1.
World J Urol. 2023.
PMID: 37528288
Free PMC article.